Terms: = Germ cell tumor AND LRIG3, Q6UXM1, 121227, ENSG00000139263, FLJ90440, KIAA3016, FLJ26573
13 results:
1. Glioma-derived lrig3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth.
Li Y; Wang W; Hou X; Huang W; Zhang P; He Y; Wang B; Duan Q; Mao F; Guo D
Cell Death Dis; 2023 Jan; 14(1):28. PubMed ID: 36639372
[TBL] [Abstract] [Full Text] [Related]
2. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications.
Mao F; Wang B; Xiao Q; Cheng F; Lei T; Guo D
J Neurol Sci; 2017 Dec; 383():56-60. PubMed ID: 29246624
[TBL] [Abstract] [Full Text] [Related]
3. lrig3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor.
Guo D; Yang H; Guo Y; Xiao Q; Mao F; Tan Y; Wan X; Wang B; Lei T
J Neurol Sci; 2015 Mar; 350(1-2):61-8. PubMed ID: 25708990
[TBL] [Abstract] [Full Text] [Related]
4. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract] [Full Text] [Related]
5. Lrig2-deficient mice are protected against PDGFB-induced glioma.
Rondahl V; Holmlund C; Karlsson T; Wang B; Faraz M; Henriksson R; Hedman H
PLoS One; 2013; 8(9):e73635. PubMed ID: 24023893
[TBL] [Abstract] [Full Text] [Related]
6. Effect of over-expressed lrig3 on cell cycle and survival of glioma cells.
Yang H; Mao F; Zhang H; Wang B; Wan F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):667. PubMed ID: 22038358
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract] [Full Text] [Related]
8. Effect of RNAi-mediated lrig3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67.
Cai MJ; Xie RF; Han L; Chen RD; Wang BF; Ye F; Guo DS; Lei T
Ai Zheng; 2009 Jan; 28(1):1-4. PubMed ID: 19448407
[TBL] [Abstract] [Full Text] [Related]
9. Effects of RNAi-mediated gene silencing of lrig3 expression on cell cycle and survival of glioma cells.
Cai M; Xie R; Han L; Chen R; Wang B; Ye F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):88-93. PubMed ID: 19224171
[TBL] [Abstract] [Full Text] [Related]
10. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of lrig3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).
Cai M; Han L; Chen R; Ye F; Wang B; Han F; Lei T; Guo D
Cancer Lett; 2009 Jun; 278(1):104-12. PubMed ID: 19200647
[TBL] [Abstract] [Full Text] [Related]
12. [lrig3 gene regulates biological activity of GL15 cell line].
Xi GF; Wu Q; Wang BF; Guo DS; Chen G; Zhang JM; Lei T
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):444-50. PubMed ID: 18925709
[TBL] [Abstract] [Full Text] [Related]
13. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract] [Full Text] [Related]
